Successful use of Argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient.

@article{Edwards2003SuccessfulUO,
  title={Successful use of Argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient.},
  author={Jeff T. Edwards and James K. Hamby and Neil K Worrall},
  journal={The Annals of thoracic surgery},
  year={2003},
  volume={75 5},
  pages={1622-4}
}
Whereas heparin is the most widely used intravenous anticoagulant in the US for the treatment of thromboembolic disease and is a seminal adjunct to many clinical procedures, its use can cause serious adverse events. Heparin-induced thrombocytopenia (HIT) has emerged as one of the most frequently seen complications of heparin therapy and can be a life… CONTINUE READING